Aspirin, non-steroidal anti-inflammatory drugs and protection from colorectal cancer: A review of the epidemiological evidence

Scandinavian Journal of Gastroenterology, Supplement

Volumn 31, Issue 220, 1996, Pages 137-141

  Weiss, H A ^a   Forman, D ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

Aspirin; Colorectal cancer; Epidemiology; NSAID

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN;

CANCER RISK; CLINICAL TRIAL; COLORECTAL CANCER; CONFERENCE PAPER; HUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; ADENOMA; CASE CONTROL STUDY; COLORECTAL TUMOR; REVIEW;

ADENOMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; HUMANS;

EID: 0030329949     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54:594-606.
2. Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality of eighteen major cancers in 1985. Implications for prevention and projections of future burdens. Int J Cancer 1993;55:891-903.
3. Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BJ, editors. SEER Cancer Statistics Review 1973-1991, US National Cancer Institute NIH Pub., No. 93-2789, Washington DC.
4. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schhuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
5. Potter JS, Slattery ML, Bostick RM, Gapstur SM. Colon cancer: a review of the epidemiology. Epi Rev 1993;15(2):499-545.
6. Giavannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995;333:6009-14.
7. Marnett LJ. Aspirin and related non-steroidal anti-inflammatory drugs as chemopreventive agents against colon cancer. Prev Med 1995;24:103-6.
8. Brooks PM, Day RO. Non-steroidal anti-inflammatory drugs - differences and similarities. N Engl J Med 1991;324:1716-25.
9. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case-control results from the Melbourne Colorectal Cancer Study. Cancer Res 1988;48: 4399-404.
10. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Aspirin use and chronic diseases: a cohort study of the elderly. Br Med J 1989;299:1247-50.
11. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S. A hypothesis: non-steroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 1991;83:355-8.
12. Thun MJ, Namboodiri MM, Heath CW. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-6.
13. Suh O, Mettlin C, Petrelli NJ. Aspirin use, cancer and polyps of the large bowel. Cancer 1993;72:1171-7.
14. Schreinemachers DM, Everson RB. Aspirin use and lung, colon and breast cancer incidence in a prospective study. Epidemiology 1994;5:138-46.
15. Peleg IL, Maibach HT, Brown SH, Wilcox CM. Aspirin and non-steroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med 1994;154:394-9.
16. Muscat JE, Stellman SD, Wynder EL. Non-steroidal anti-inflammatory drugs and colorectal cancer. Cancer 1994;74: 1847-54.
17. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett W. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994; 121:241-6.
18. Greenberg ER, Baron JA, Freeman DH, Mandel JS, Haile R. Reduced risk of large-bowel adenomas among aspirin users. J Natl Cancer Inst 1993;85:912-6.
19. Logan RFA, Little J, Hawtin PG, Hardcastle JD. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br Med J 1993:307:285-9.